We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.64%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$106B
AUM Growth
+$2.27B
Cap. Flow
-$488M
Cap. Flow %
-0.46%
Top 10 Hldgs %
30.07%
Holding
4,478
New
179
Increased
2,056
Reduced
1,848
Closed
61

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$101M
2
GEV icon
GE Vernova
GEV
+$75.4M
3
CRH icon
CRH
CRH
+$48.5M
4
CRWD icon
CrowdStrike
CRWD
+$45.8M
5
DELL icon
Dell
DELL
+$35.8M

Sector Composition

Rank Sector Weight
1 Technology 30.98%
2 Financials 12.55%
3 Healthcare 11.48%
4 Consumer Discretionary 10.52%
5 Industrials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACHL
3701
DELISTED
Achilles Therapeutics
ACHL
$3.65K ﹤0.01%
4,480
+966
+27% +$849
BNR
3702
Burning Rock Biotech
BNR
$93.7M
$3.65K ﹤0.01%
580
-1
-0.2% -$8
GORV
3703
DELISTED
Lazydays
GORV
$3.61K ﹤0.01%
47
-354
-88% -$37.6K
UFI icon
3704
UNIFI
UFI
$128M
$3.59K ﹤0.01%
609
LFVN icon
3705
LifeVantage
LFVN
$83M
$3.57K ﹤0.01%
556
EARN
3706
Ellington Residential Mortgage REIT
EARN
$163M
$3.56K ﹤0.01%
513
VXRT
3707
DELISTED
Vaxart
VXRT
$3.51K ﹤0.01%
5,264
-262
-5% -$217
HKD
3708
AMTD Digital
HKD
$525M
$3.5K ﹤0.01%
969
+279
+40% +$988
RAIL icon
3709
FreightCar America
RAIL
$253M
$3.49K ﹤0.01%
1,000
-1
-0.1% -$4
SYRS
3710
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$3.4K ﹤0.01%
659
RLMD icon
3711
Relmada Therapeutics
RLMD
$564M
$3.38K ﹤0.01%
1,125
-49
-4% -$177
GHG
3712
GreenTree Hospitality
GHG
$115M
$3.37K ﹤0.01%
1,387
STN icon
3713
Stantec
STN
$8.34B
$3.34K ﹤0.01%
40
+3
+8% +$244
VLD
3714
DELISTED
Velo3D, Inc.
VLD
$3.33K ﹤0.01%
1,004
-2,128
-68% -$16.9K
CMRX
3715
DELISTED
Chimerix, Inc.
CMRX
$3.27K ﹤0.01%
3,730
-1,661
-31% -$1.57K
CMCM
3716
Cheetah Mobile
CMCM
$101M
$3.25K ﹤0.01%
816
SUP
3717
DELISTED
Superior Industries International
SUP
$3.24K ﹤0.01%
998
-1,202
-55% -$4.33K
SCNI
3718
Scinai Immunotherapeutics
SCNI
$1.34M
$3.24K ﹤0.01%
1,138
+473
+71% +$1.96K
YQ
3719
17 Education & Technology Group
YQ
$19.5M
$3.21K ﹤0.01%
1,545
SQNS
3720
Sequans Communications SA
SQNS
$41.8M
$3.2K ﹤0.01%
255
CCJ icon
3721
Cameco
CCJ
$40.8B
$3.05K ﹤0.01%
62
-3
-5% -$152
AHI
3722
DELISTED
Advanced Health Intelligence Ltd
AHI
$2.95K ﹤0.01%
1,965
AMBR
3723
Amber International Holding Ltd
AMBR
$128M
$2.89K ﹤0.01%
2,279
SPRC icon
3724
SciSparc
SPRC
$3.85M
$2.87K ﹤0.01%
18
TMIC
3725
DELISTED
TREND MICRO INC SPONS ADR-NEW
TMIC
$2.76K ﹤0.01%
70

Similar funds

RhumbLine Advisers's Q2 2024 Portfolio in Review

As of Q2 2024, RhumbLine Advisers held 4,478 positions worth $106B, up 2.2% from $104B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

RhumbLine Advisers's Q2 2024 filing shows 179 new, 2,056 increased, 1,848 reduced and 61 closed positions. Its largest new stake was GE Vernova: 475,685 shares worth $81.6M. The largest sale was iShares Russell 1000 ETF, an estimated $180M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q2 2024 buy was GE Vernova: 475,685 shares worth $81.6M.
  • RhumbLine Advisers added most to ExxonMobil in Q2 2024, an estimated $101M increase.
  • RhumbLine Advisers's biggest Q2 2024 reduction was iShares Russell 1000 ETF, cutting an estimated $180M.
  • RhumbLine Advisers fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $121M.
  • RhumbLine Advisers's ten largest holdings make up 30% of its $106B portfolio in Q2 2024.
  • RhumbLine Advisers opened 179 new positions and closed 61 in Q2 2024.
  • RhumbLine Advisers's portfolio value rose 2.2% quarter-over-quarter to $106B.

Based on RhumbLine Advisers's 13F filing for Q2 2024, filed 1 Aug 2024.